NCT00567788View on ClinicalTrials.gov

Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

July 31, 2008

Conditions
Glaucoma, Angle-Closure
Interventions
DRUG

Latanoprost-Bimatoprost

latanoprost 0.005% once daily followed by bimatoprost 0.03%

DRUG

Bimatoporost-Latanoprost

bimatoprost 0.03% once daily followed by latanoprost 0.005%

Trial Locations (1)

168751

Singapore National Eye Centre, Singapore

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Singapore National Eye Centre

OTHER_GOV